Deals dominated the week as Green Cross and Heartland surged.
USX-listed firm sees fresh semiconductor sector order from Samsung as it also branches out into life sciences.
Second stage of $37m transaction by New York-based David Liptak will require shareholder approval in January.
The amount of beneficiary income paid to people earning more than $180,000 has halved.
Annual meeting hears infant formula marketer’s priority is controlling production licences for exports to China.
Listed hotel company and its subsidiary have been censured for multiple breaches by the NZ Markets Disciplinary Tribunal.
The investor in large retail property sites says its operating earnings remain resilient thanks to its quality portfolio, however.
Investment company says its 48% owned datacentre business CDC is experiencing an 'unprecedented surge in demand'.
Software company attracts investment from SmartPayroll’s Phil Richards.
The retailer has been stamped with an 'underperform' label following first quarter figures.
